M Rougemont
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
Hampel B, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H, Braun D, Fehr J, Schmidt A, Nicca D, Kusejko K, Kouyos R, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Swiss HIV Cohort Study Group. Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV Med 2019
Dec 18, 2019Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
Dec 18, 2019HIV Med 2019
Hampel B, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H F, Braun D L, Fehr J, Schmidt A J, Nicca D, Kusejko K, Kouyos R D, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule Patrizia, Swiss HIV Cohort Study Group
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study
Salazar-Vizcaya L, Rauch A, Keiser O, Günthard H, Wandeler G, Rougemont M, Schmid P, Stöckle M, Delaloye J, Bernasconi E, Estill J, Braun D, Fehr J, Kouyos R, Swiss HIV Cohort Study. On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study. J Viral Hepat 2017; 25:10-18.
Aug 23, 2017On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study
Aug 23, 2017J Viral Hepat 2017; 25:10-18
Salazar-Vizcaya L, Rauch A, Keiser O, Günthard H F, Wandeler G, Rougemont M, Schmid Patrick, Stöckle M, Delaloye J, Bernasconi E, Estill J, Braun D, Fehr J, Kouyos R D, Swiss HIV Cohort Study